Format

Send to

Choose Destination
Br J Cancer. 2007 Aug 6;97(3):384-90. Epub 2007 Jun 26.

Analysis of a panel of antibodies to APC reveals consistent activity towards an unidentified protein.

Author information

1
North West Cancer Research Fund Institute, School of Biological Sciences, University of Wales Bangor, Bangor LL57 2UW, UK. j.a.wakeman@bangor.ac.uk

Abstract

Acquisition of truncating mutations in the adenomatous polyposis coli (APC) protein underlies the progression of the majority of sporadic and familial colorectal cancers. As such, the localisation patterns and interacting partners of APC have been extensively studied in a range of systems, relying on the use of a broad panel of antibodies. Until recently, antibodies to APC have been used largely unchecked. However, several recent reports have been invaluable in clarifying the use of a number of antibodies commonly used to detect APC. Here, we analyse the specificity of a further subset of antibodies to APC. We used a panel of six commercially available antibodies (directed to the amino and carboxy termini of APC) and confirm the detection of full-length APC by immunoblotting. We demonstrate that a 150 kDa protein, also reproducibly detected by this panel of antibodies, is unlikely to be APC. We present data for the immunological staining patterns of the APC antibodies and validate the results through RNAi. Using this approach, we confirm that the apical staining pattern, observed by immunofluorescence and previously reported in cell systems, is unlikely to be APC. Finally, we present our data as a summary of APC-antibody specificities for APC.

PMID:
17595655
PMCID:
PMC2360331
DOI:
10.1038/sj.bjc.6603873
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center